HNPCC

Clinical trials for HNPCC explained in plain language.

Never miss a new study

Get alerted when new HNPCC trials appear

Sign up with your email to follow new studies for HNPCC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

Promising new combo targets tough head and neck cancer

Disease control Not yet recruiting

This phase 2 trial tests a combination of two drugs—becotatug vedotin (a targeted therapy) and pucotenlimab (an immunotherapy)—as a first treatment for advanced head and neck squamous cell carcinoma. It is for patients whose cancer has returned or spread and who cannot tolerate p…

Matched conditions: HNPCC

Phase: PHASE2 • Sponsor: Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center • Aim: Disease control

Last updated Jun 27, 2026 13:02 UTC

HNPCC

Get alerted when new HNPCC trials appear

Promising new combo targets tough head and neck cancer